Mirum Pharmaceuticals, Inc. filed 1 current report with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-09-08. Between them they name 2 people, with 1 appointment and 1 departure. Each change below is quoted from the filing and linked to it.
Every change, newest first
Appointed: Rob Myers, Chief Medical Officer
On September 8, 2026, Mirum Pharmaceuticals, Inc. (the "Company") announced that, on September 2, 2026, the Company's Board of Directors appointed Rob Myers, M.D., to succeed Joanne Quan, M.D., as the Company's Chief Medical Officer, effective upon Dr. Myers' beginning employment with the Company, which employment is expected to begin on September 21, 2026.
Departing: Joanne Quan, Chief Medical Officer, effective 2026-09-02
Dr. Quan ceased to serve as the Company's Chief Medical Officer effective September 2, 2026, and her termination of employment with the Company is expected to occur on October 19, 2026 (the actual date of Dr. Quan's termination of employment, the "Separation Date").
Find people with the same kind of experience as the Chief Medical Officer at Mirum Pharmaceuticals, Inc., with the record behind each one.
Find candidates like Chief Medical Officer at Mirum Pharmaceuticals, Inc.New leaders review vendors and budgets in their first months. Get an alert the next time Mirum Pharmaceuticals, Inc. is in the news or changes leadership.
Get an alert when Mirum Pharmaceuticals, Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for Mirum Pharmaceuticals, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.